Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06131281 · ClinicalTrials.gov registry record · NA

Comparing Reduction With ESD- Versus APC-TORe

A NA study of Obesity and Weight Gain, sponsored by Stephen Firkins.

Active
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT06131281: Active NA study of Obesity and Weight Gain, sponsored by Stephen Firkins.

NCT06131281 is a NA study of Obesity and Weight Gain that is active but no longer recruiting, run by Stephen Firkins. The registered enrollment target is 70 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06131281, a NA study of Obesity and Weight Gain, is active but no longer recruiting, sponsored by Stephen Firkins.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to compare two variations of the same procedure used to assist with weight loss in patients who have a history of Roux-en-Y gastric bypass who have experienced weight regain. The procedure being studied is called the Transoral Outlet Reduction (TORe), and the trial will compare two different ways to complete the TORe procedure. The main question\[s\] it aims to answer are: * Which variation of the TORe procedure results in more weight loss? * Which variation of the TORe is safer? Participants who are eligible and willing to undergo the TORe procedure to assist with weight loss will have the procedure completed either one of the two ways. All other care will be exactly the same between the two groups. Researchers will compare outcomes between the two procedure variations, looking at which one results in more weight loss, is more successful, and safer.

Primary Outcome

Percent total body weight change 6 months following TORe procedure

Interventions

  • PROCEDURE E-TORe
  • PROCEDURE c-TORe

Study Locations (1)

Ohio

  • Cleveland Clinic Foundation - Cleveland

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2023-10-02
Est. Completion 2027-04
Phase NA
Stephen Firkins

2 total trials

What the registry record for NCT06131281 still lists

NCT06131281 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which E-TORe is the first listed.

NCT06131281 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06131281 about?

NCT06131281 is a clinical study titled "Comparing Reduction With ESD- Versus APC-TORe". The goal of this clinical trial is to compare two variations of the same procedure used to assist with weight loss in patients who have a history of Roux-en-Y gastric bypass who have experienced weight regain. The procedure being studied is called the Transoral Outlet Reduction (TORe), and the trial...

What is the current status of trial NCT06131281?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2023-10-02. Estimated completion is 2027-04.

What conditions does trial NCT06131281 study?

This clinical trial studies the following conditions: Obesity, Weight Gain, Roux-en-y Anastomosis Site.

What interventions are being tested in trial NCT06131281?

The interventions under investigation include: E-TORe (PROCEDURE), c-TORe (PROCEDURE).

Who is sponsoring clinical trial NCT06131281?

This trial is sponsored by Stephen Firkins, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06131281 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06131281's enrollment target sits among peer trials

70 595th of 1053 higher than 449 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06131281, the US trial registry maintained by the National Library of Medicine. NCT06131281 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.